000 | 01059 a2200301 4500 | ||
---|---|---|---|
005 | 20250511230158.0 | ||
264 | 0 | _c19901119 | |
008 | 199011s 0 0 eng d | ||
022 | _a0142-2782 | ||
024 | 7 |
_a10.1002/bdd.2510110608 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorse, I S | |
245 | 0 | 0 |
_aPharmacokinetics and safety of single oral doses of lomefloxacin. _h[electronic resource] |
260 |
_bBiopharmaceutics & drug disposition _c |
||
300 |
_a543-51 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _a4-Quinolones |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFluoroquinolones |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aQuinolones |
773 | 0 |
_tBiopharmaceutics & drug disposition _gvol. 11 _gno. 6 _gp. 543-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/bdd.2510110608 _zAvailable from publisher's website |
999 |
_c2213438 _d2213438 |